- Report
- March 2025
- 250 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- September 2025
- 398 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- November 2024
- 183 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- May 2025
- 317 Pages
Global
From €4191EUR$4,750USD£3,625GBP
- Report
- January 2025
- 255 Pages
Global
From €4368EUR$4,950USD£3,778GBP
- Report
- December 2024
- 274 Pages
Global
From €4368EUR$4,950USD£3,778GBP
- Report
- November 2024
- 130 Pages
Global
From €4103EUR$4,650USD£3,549GBP
- Report
- June 2025
- 150 Pages
Global
From €5250EUR$5,950USD£4,541GBP
- Report
- January 2025
- 145 Pages
Global
From €5250EUR$5,950USD£4,541GBP
- Report
- June 2025
- 170 Pages
Global
From €5250EUR$5,950USD£4,541GBP
- Report
- May 2025
- 262 Pages
Global
From €5250EUR$5,950USD£4,541GBP
- Report
- August 2025
- 183 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 185 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 188 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 199 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 198 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 197 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 192 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 181 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 192 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more